MINERVAX ApS: Financial statements 2021
CVR: 32673287
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
MINERVAX ApS (CVR 32673287) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -57,828,860 and a net result of DKK -61,922,783 compared with DKK -19,512,889 the year before. Equity in the 2021 report amounted to DKK 98,662,946. The solvency ratio was 87.6%. The company had 7 employees in the financial year.
- Gross Profit
- DKK -57,828,860
- Profit/Loss
- DKK -61,922,783
- Equity
- DKK 98,662,946
- Total Assets
- DKK 112,669,550
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -57.8 mio. | -61.9 mio. | 98.7 mio. | 7 |
| 2020 | - | -16.8 mio. | -19.5 mio. | 156 mio. | 1 |
| 2019 | - | -25.9 mio. | -24.8 mio. | -29.7 mio. | 1 |
| 2018 | - | -12.1 mio. | -11.5 mio. | -4.9 mio. | 1 |
| 2017 | - | -6 mio. | -4.9 mio. | 6.6 mio. | 2 |
Official annual report
Find more companies like MINERVAX ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
As of July 1, 2021, Dr. Gerd Werner Zettlmeissl has joined the board of directors of MINERVAX ApS.
As of July 1, 2021, Ingelise Saunders has left the board of directors of MINERVAX ApS.
MINERVAX ApS has published its annual report for 2020. Gross profit came to DKK -16,782,181, and the net result was DKK -19,512,889.
About MINERVAX ApS
MINERVAX ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Per Bo Pedersen Fischer. The board consists of Veronica Gambillara Fonck (chair), Bita Sehat, Christopher J. Gagliardi and Emmanuelle Coutanceau. The company's owners include Novo Holdings A/S, SUNSTONE LIFE SCIENCE VENTURES FUND III K/S and Wellington Partners Life Sciences V GmbH & Co. KG. The company has 28 employees (2026). In 2025, the company reported a net result of EUR -31,530,000 compared with EUR -29,126,000 the year before. Equity in the 2025 report amounted to EUR 9,787,000.